The MIT Sloan BioInnovations Conference is a premier gathering of more than 200 healthcare pioneers from a broad range of industries: from bio-pharma and medical devices to healthcare providers and healthcare IT.
This year’s keynote speakers include MIT Institute Professor Robert Langer, Vertex CEO Matthew Emmens, and Genzyme EVP Peter Wirth, Esq. Panel discussions will include healthcare reform, emerging markets, bringing innovation to market, and building collaborative networks.
Hosted by the MIT Sloan Biomedical Business Club, the conference will take place on Friday, March 12, from 9 a.m. to 4 p.m. at the Marriott in Kendall Square. All members of the MIT community as well as the general public are invited to register for this event.
To learn more or to register, visit the BioInnovations web site.
This year’s keynote speakers include MIT Institute Professor Robert Langer, Vertex CEO Matthew Emmens, and Genzyme EVP Peter Wirth, Esq. Panel discussions will include healthcare reform, emerging markets, bringing innovation to market, and building collaborative networks.
Hosted by the MIT Sloan Biomedical Business Club, the conference will take place on Friday, March 12, from 9 a.m. to 4 p.m. at the Marriott in Kendall Square. All members of the MIT community as well as the general public are invited to register for this event.
To learn more or to register, visit the BioInnovations web site.
